Robert Hubbard - BlackRock Health Independent Trustee
BME Etf | USD 40.10 0.21 0.52% |
Dr. Robert Glenn Hubbard, Ph.D., serves as Independent Trustee of BlackRock Health Science Trust. Dr. Hubbard has served in numerous roles in the field of economics, including as the Chairman of the U.S. Council of Economic Advisers of the President of the United States. Dr. Hubbard serves as the Dean of Columbia Business School, has served as a member of the Columbia Faculty and as a Visiting Professor at the John F. Kennedy School of Government at Harvard University, the Harvard Business School and the University of Chicago. Dr. Hubbards experience as an adviser to the President of the United States adds a dimension of balance to the Funds governance and provides perspective on economic issues. Dr. Hubbards service on the boards of ADP and Metropolitan Life Insurance Company provides the Boards with the benefit of his experience with the management practices of other financial companies. Dr. Hubbards longstanding service on the boards of the ClosedEnd Complex also provides him with a specific understanding of the Funds, their operations, and the business and regulatory issues facing the Funds
Age | 63 |
Tenure | 18 years |
Address | 50 Hudson Yards, New York, NY, United States, 10001 |
Phone | 212 810 5300 |
Web | https://www.blackrock.com/investing/products/24022 |
Robert Hubbard Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert Hubbard against BlackRock Health etf is an integral part of due diligence when investing in BlackRock Health. Robert Hubbard insider activity provides valuable insight into whether BlackRock Health is net buyers or sellers over its current business cycle. Note, BlackRock Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell BlackRock Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert Hubbard over a month ago Acquisition by Robert Hubbard of 890 shares of BlackRock Limited subject to Rule 16b-3 | ||
Robert Hubbard over three months ago Acquisition by Robert Hubbard of 903 shares of BlackRock Limited subject to Rule 16b-3 | ||
Robert Hubbard over three months ago Acquisition by Robert Hubbard of 871 shares of BlackRock Limited subject to Rule 16b-3 | ||
Robert Hubbard over three months ago Acquisition by Robert Hubbard of 918 shares of MetLife at 81.78 subject to Rule 16b-3 |
BlackRock Health Management Efficiency
BlackRock Health's management efficiency ratios could be used to measure how well BlackRock Health manages its routine affairs as well as how well it operates its assets and liabilities.BlackRock Health Sciences has 60.69 K in debt with debt to equity (D/E) ratio of 0.0, which may show that the company is not taking advantage of profits from borrowing. BlackRock Health Sciences has a current ratio of 0.35, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist BlackRock Health until it has trouble settling it off, either with new capital or with free cash flow. So, BlackRock Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BlackRock Health Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BlackRock to invest in growth at high rates of return. When we think about BlackRock Health's use of debt, we should always consider it together with cash and equity.
Similar Fund Executives
Showing other executives | One Year Return | ||
Henry Gabbay | Blackrock Enhanced Capital | 72 | |
Charles Park | Blackrock Resources Commodities | 54 | |
Susan Sutherland | Eaton Vance Tax | 64 | |
Lisa Phelan | Cohen And Steers | 51 | |
Jay Fife | BlackRock Science Tech | 51 | |
Helen Peters | Eaton Vance Enhanced | 73 | |
Robert Fairbairn | Blackrock Enhanced Capital | 56 | |
Helen Peters | Eaton Vance Tax | 73 | |
Michael Castellano | BlackRock Science Tech | 75 | |
James Kirchner | Eaton Vance Enhanced | 54 | |
Janey Ahn | Blackrock Resources Commodities | 46 | |
George Gorman | Eaton Vance Tax | 69 | |
Susan Sutherland | Eaton Vance Enhanced | 64 | |
Jay Fife | Blackrock Resources Commodities | 51 | |
Scott Wennerholm | Eaton Vance Tax | 62 | |
James Kirchner | Eaton Vance Enhanced | 54 | |
Helen Peters | Eaton Vance Enhanced | 73 | |
Thomas Faust | Eaton Vance Enhanced | 63 | |
Cynthia Frost | Eaton Vance Enhanced | 60 | |
Valerie Mosley | Eaton Vance Tax | 61 | |
James Kirchner | Eaton Vance Tax Managed | 54 |
Management Performance
Return On Equity | 0.0901 | ||||
Return On Asset | 0.0017 |
BlackRock Health Sciences Money Managers
CFA CFA, Portfolio Mang | ||
Erin Xie, Portfolio Manager | ||
Robert Hubbard, Independent Trustee | ||
Karen Robards, Independent Vice Chairman of the Board of Trustees | ||
Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
Charles Park, Chief Compliance Officer and Anti- Money Laundering Officer | ||
Frank Fabozzi, Independent Trustee | ||
J Holloman, Independent Trustee | ||
Janey Ahn, Secretary | ||
John Perlowski, President, Chief Executive Officer, Trustee | ||
Michael Castellano, Independent Trustee | ||
Xiang Liu, Portfolio Manager | ||
Cynthia Egan, Independent Trustee | ||
Kyle CFA, Portfolio Manager | ||
Jay Fife, Treasurer | ||
Jonathan Diorio, Vice President | ||
Robert Fairbairn, Trustee | ||
Christopher Accettella, Portfolio Manager | ||
Thomas CFA, Portfolio Manager | ||
Trent Walker, Chief Financial Officer | ||
Catherine Lynch, Independent Trustee | ||
Jeffrey Lee, Portfolio Manager | ||
Stayce Harris, Independent Trustee | ||
W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0901 | ||||
Return On Asset | 0.0017 | ||||
Profit Margin | 6.84 % | ||||
Operating Margin | 0.21 % | ||||
Current Valuation | 560.18 M | ||||
Shares Outstanding | 13.26 M | ||||
Shares Owned By Insiders | 0.61 % | ||||
Shares Owned By Institutions | 22.49 % | ||||
Number Of Shares Shorted | 16.82 K | ||||
Price To Earning | 6.69 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BlackRock Etf
BlackRock Health financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Health security.